DK0904352T3 - Cellelinie - Google Patents

Cellelinie

Info

Publication number
DK0904352T3
DK0904352T3 DK96919794T DK96919794T DK0904352T3 DK 0904352 T3 DK0904352 T3 DK 0904352T3 DK 96919794 T DK96919794 T DK 96919794T DK 96919794 T DK96919794 T DK 96919794T DK 0904352 T3 DK0904352 T3 DK 0904352T3
Authority
DK
Denmark
Prior art keywords
cell line
emplyed
alpha
expression
useful
Prior art date
Application number
DK96919794T
Other languages
English (en)
Inventor
Peter Anthony Everett
Brendan Patrick Hughes
Cornelia Rossman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0904352T3 publication Critical patent/DK0904352T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Semiconductor Lasers (AREA)
  • Semiconductor Memories (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK96919794T 1996-05-22 1996-05-22 Cellelinie DK0904352T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/002185 WO1997044440A1 (en) 1996-05-22 1996-05-22 Cell line

Publications (1)

Publication Number Publication Date
DK0904352T3 true DK0904352T3 (da) 2007-10-29

Family

ID=8166225

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919794T DK0904352T3 (da) 1996-05-22 1996-05-22 Cellelinie

Country Status (8)

Country Link
EP (1) EP0904352B1 (da)
JP (1) JP3249134B2 (da)
AT (1) ATE366802T1 (da)
DE (1) DE69637159T2 (da)
DK (1) DK0904352T3 (da)
ES (1) ES2288755T3 (da)
PT (1) PT904352E (da)
WO (1) WO1997044440A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4536194B2 (ja) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 安定な注射用製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074808A3 (en) * 1981-09-16 1984-07-04 University Patents, Inc. Recombinant method and materials
WO1993000103A1 (en) * 1991-06-21 1993-01-07 The Wistar Institute Of Anatomy And Biology Chimeric envelope proteins for viral targeting

Also Published As

Publication number Publication date
JPH11513891A (ja) 1999-11-30
JP3249134B2 (ja) 2002-01-21
EP0904352B1 (en) 2007-07-11
EP0904352A1 (en) 1999-03-31
ATE366802T1 (de) 2007-08-15
PT904352E (pt) 2007-10-01
ES2288755T3 (es) 2008-01-16
WO1997044440A1 (en) 1997-11-27
DE69637159T2 (de) 2008-03-20
DE69637159D1 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
NL194066B (nl) Dentale glasionomeercementpreparaten.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE59807369D1 (de) Medizinische Bandage
IL90381A0 (en) Expression of retrovirus gag protein in eukaryotic cells
DK40986D0 (da) 4h-1-benzopyran-4-oner og deres svovlholdige analoge, og farmaceutiske kompositioner indeholdende forbindelserne
DK141684A (da) Dentalglasur
NO861517L (no) Stabilt smakstoffholdig tannpleiemiddel.
DE3777263D1 (de) Lichtbogenlampenleistungsversorgung.
DE69637159D1 (de) Zelllinie
ES2152315T3 (es) Xamoneline tartrato.
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában
ATA237086A (de) Backenbrecher
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
FI861711L (fi) Tandlaekararbetsplats.
ATE90195T1 (de) Minoxidil-gel.
NO891691D0 (no) Rekombinant gag-forloeper for hiv.
FI901294A7 (fi) Bipolaarinen elektrodi paristoja varten
DE3768818D1 (de) Eingangswechselspannungsunabhaengige leistungsversorgung.
ATE332923T1 (de) Cr1 fragmente und deren verwendung
IT1303823B1 (it) Composizioni farmaceutiche a base di proteine.
AT399830B (de) Backenbrecher
TR200000916T2 (tr) İkameli piperidin türevleri.
IT215687Z2 (it) Piano di cottura con dispositivo di sicurezza d'alimentazione.
ES286561U (es) Envase perfeccionado
KR880019998U (ko) 보조가스통을 이용한 가스 공급장치